000 | 01089 a2200325 4500 | ||
---|---|---|---|
005 | 20250512061137.0 | ||
264 | 0 | _c19870605 | |
008 | 198706s 0 0 eng d | ||
022 | _a0732-9482 | ||
024 | 7 |
_a10.1089/cdd.1986.3.239 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBalis, F M | |
245 | 0 | 0 |
_aThe influence of route of administration on the hepatic uptake of methotrexate. _h[electronic resource] |
260 |
_bCancer drug delivery _c1986 |
||
300 |
_a239-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aLiver _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
700 | 1 | _aMurphy, R F | |
700 | 1 | _aLester, C M | |
700 | 1 | _aPoplack, D G | |
773 | 0 |
_tCancer drug delivery _gvol. 3 _gno. 4 _gp. 239-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/cdd.1986.3.239 _zAvailable from publisher's website |
999 |
_c3573560 _d3573560 |